TrialClinical pharmacokinetics2007

Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease.

Céline Dartois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.